Aarkstore -TGR5 Receptor Agonists -Pipeline Insights, 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore -TGR5 Receptor Agonists -Pipeline Insights, 2014 PowerPoint presentation | free to download - id: 6c10d8-YjNlY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore -TGR5 Receptor Agonists -Pipeline Insights, 2014

Description:

DelveInsights,TGR5 Receptor Agonists-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under TGR5 Receptor Agonist – PowerPoint PPT presentation

Number of Views:15

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore -TGR5 Receptor Agonists -Pipeline Insights, 2014


1
TGR5 Receptor Agonists -Pipeline Insights, 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/76037/tgr5-receptor-agonists-pipeline-insights-2
    014

2
Summary
  • DelveInsights,TGR5 Receptor Agonists-Pipeline
    Insights, 2014, report provides comprehensive
    insights about pipeline drugs across this
    mechanism of action (MOA). A key objective of the
    report is to establish the understanding for all
    the pipeline drugs that fall under TGR5 Receptor
    Agonists. This report provides information on the
    therapeutic development based on the TGR5
    Receptor Agonists dealing with mechanism of
    action, comparative analysis at various stages
    covering Filed, Phase III, Phase II, Phase I, IND
    filed, Preclinical, Discovery and unknown stages,
    therapeutics assessment by monotherapy and
    combination products and molecule type drug
    information. The report also covers the companies
    information involved in the therapeutic
    development of the products. It also has
    highlighted the discontinued and dormant products.

3
Summary
  • Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts. Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases. Please note this report
    requires certain updates. We have all the
    information available but require 3 business days
    to complete the process and ensure it is as
    up-to-date as possible. Certain sections in the
    report may be removed or altered based on the
    availability and relevance of data for the
    indicated mechanism of action. 

4
Summary
  • Scope 
  • The report provides a snapshot of the global
    therapeutic landscape of TGR5 Receptor
    Agonists The report provides pipeline products
    under drug profile section which includes product
    description, MOA, licensors collaborators,
    development partner and chemical
    information Coverage of the TGR5 Receptor
    Agonists pipeline on the basis of target, MOA,
    route of administration, technology involved and
    molecule type The report reviews key players
    involved in the therapeutics development for TGR5
    Receptor Agonists and also provide company
    profiling The report also gives the information
    of dormant and discontinued pipeline
    projects  Pipeline products coverage based on
    various stages of development ranging from
    preregistration till discovery and undisclosed
    stages  Provides pipeline assessment by
    monotherapy and combination therapy products,
    stage of development and molecule type

5
Summary
  • Reasons to buy Complete MOA intelligence and
    complete understanding over therapeutics
    development for TGR5 Receptor Agonists Identify
    the relationship between the drugs and use it for
    target finding, drug repurposing, and precision
    medicine. Devise corrective measures for pipeline
    projects by understanding TGR5 Receptor Agonists
    pipeline depth and focus of Indication
    therapeutics  Developing strategic initiatives to
    support your drug development activities. Optimize
    your portfolio and keep you in touch with the
    rapidly changing pharmaceutical markets, and make
    the best decisions for your business.

6
Summary
  • Develop and design in licensing and out licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope Provides
    strategically significant competitor information,
    analysis, and insights to formulate effective RD
    development strategies  Modify the therapeutic
    portfolio by identifying discontinued projects
    and understanding the factors that drove them
    from pipeline Gaining a Full Picture of the
    Competitive Landscape for Evidence based Decisions

7
Table of Content
  • TGR5 Receptor Agonists Overview TGR5 Receptor
    Agonists Disease Associated TGR5 Receptor
    Agonists Pipeline Therapeutics TGR5 Receptor
    Agonists Therapeutics under Development by
    Companies  TGR5 Receptor Agonists Late Stage
    Products (Filed and Phase III) Comparative
    Analysis  TGR5 Receptor Agonists Mid Clinical
    Stage Products (Phase II) Comparative
    Analysis  TGR5 Receptor Agonists Early Clinical
    Stage Products (Phase I and IND
    Filed) Comparative Analysis  TGR5 Receptor
    Agonists Discovery and Pre-Clinical Stage
    Products  Comparative Analysis  Drug Candidate
    Profiles

8
Table of Content
  • TGR5 Receptor Agonists Therapeutics
    Assessment  Assessment by Monotherapy
    Products  Assessment by Combination
    Products  Assessment by Route of
    Administration  Assessment by Molecule Type  TGR5
    Receptor Agonists Discontinued Products  TGR5
    Receptor Agonists Dormant Products Companies
    Involved in Therapeutics Development for TGR5
    Receptor Agonists  Appendix  Methodology  Contact
    Us  Disclaimer

9
List of Tables
  • Number of Products under Development for TGR5
    Receptor Agonists by Therapy Area, 2014 Number of
    Products under Development for TGR5 Receptor
    Agonists, 2014 Number of Products under
    Development by Companies  Comparative Analysis by
    Late Clinical Stage Products (Filed and Phase
    III), 2014 Comparative Analysis Mid Clinical
    Stage Products (Phase II), 2014 Comparative
    Analysis Early Clinical Stage Products (Phase I
    and IND Filed), 2014 Comparative Analysis
    Discovery and Pre-Clinical Stage Products,
    2014 Drug Candidates Profiles

10
List of Tables
  • TGR5 Receptor Agonists Assessment by Monotherapy
    Products  TGR5 Receptor Agonists Assessment by
    Combination Products  TGR5 Receptor Agonists
    Assessment by Route of Administration  TGR5
    Receptor Agonists Assessment by Stage and Route
    of Administration  TGR5 Receptor Agonists
    Assessment by Molecule Type  TGR5 Receptor
    Agonists Assessment by Stage and Molecule
    Type  TGR5 Receptor Agonists Therapeutics
    Discontinued Products  TGR5 Receptor Agonists
    Therapeutics Dormant Products Products under
    Development by Companies, 2014

11
List of Figures
  • Number of Products under Development for TGR5
    Receptor Agonists by Therapy Area, 2014 Number of
    Products under Development for TGR5 Receptor
    Agonists, 2014 Late Clinical Stage Products
    (Filed and Phase III), 2014 Mid Clinical Stage
    Products (Phase II), 2014 Early Clinical Stage
    Products (Phase I and IND Filed), 2014 Discovery
    and Pre-Clinical Stage Products, 2014 TGR5
    Receptor Agonists Assessment by Monotherapy
    Products  TGR5 Receptor Agonists Assessment by
    Combination Products  TGR5 Receptor Agonists
    Assessment by Route of Administration  TGR5
    Receptor Agonists Assessment by Stage and Route
    of Administration  TGR5 Receptor Agonists
    Assessment by Molecule Type  TGR5 Receptor
    Agonists Assessment by Stage and Molecule
    TypeMolecule Type

12
Related Reports
  • 2015 Worldwide Medical Laboratories
    Industry-Industry Market Report
  • 2015 Worldwide Pharmaceutical Preparation Mfg.
    Industry-Industry Market Report
  • OncoPlex Diagnostics - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • MetaStat, Inc. - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Advanced Cell Diagnostics, Inc. - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • Ascension Health - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Accretive Health, Inc. (ACHI) - Strategic SWOT
    Analysis Review
  • Jazz Pharmaceuticals plc (JAZZ) - Financial and
    Strategic SWOT Analysis Review
  • Pharmstandard (PHST) - Financial and Strategic
    SWOT Analysis Review
  • GLG Life Tech Corporation (GLG) - Financial and
    Strategic SWOT Analysis Review

13
  • TGR5 Receptor Agonists -Pipeline Insights, 2014
  • Published Dec. 2014 60 Pages
  • DelveInsights,TGR5 Receptor Agonists-Pipeline
    Insights, 2014, report provides comprehensive
    insights about pipeline drugs across this
    mechanism of action (MOA).
    Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor, B-Wing,
Mahaavir Icon,  Plot No.- 89 90,
Sector-15, CBD-Belapur, Navi Mumbai
400614,  Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com